Varenicline Kit
Product Images NDC 71921-307

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 71921-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Figure 1)

A bar chart comparing the percentage values related to Varenicline tartrate under various study conditions. Four separate studies (Study 2, Study 3, Study 4, Study 5) are displayed with bars representing Varenicline at different dosages, bupropion, and placebo. The y-axis shows percentages from 0% to 60%, with error bars on the data points.*

FDA Label Image

Fig 2 (Figure 2)

A bar chart comparing percent values across four studies for Varenicline at 0.5 mg and 1 mg doses versus placebo, and Bupropion SR 150 mg BID versus placebo. The chart displays mean values with error bars for each treatment group in each study, illustrating treatment effects compared to placebo.*

FDA Label Image

Fig 3 (Figure 3)

A line graph comparing the percentage of continuous abstinent individuals over nontreatment follow-up weeks for Varenicline 1.0 mg twice daily versus placebo. The x-axis shows weeks of follow-up, and the y-axis shows percentage continuous abstinent, with Varenicline consistently higher than placebo.*

FDA Label Image

Vareni-container-label-1mg (Label 1mg)

Label for Varenicline Tablets 1 mg, film-coated oral tablets by Florida Pharmaceutical Products, LLC. The label shows a package size of 56 tablets and includes storage instructions, manufacturer details (Indoco Remedies Limited, India), and a barcode. The label emphasizes dispensing the enclosed medication guide with each patient.*

FDA Label Image

Vareni-starting-carton-label (Label Starting Month Box)

This text panel provides dosage and use instructions for Varenicline Tartrate tablets, including detailed daily dosing schedules from day 1 to day 28 with strength increments of 0.5 mg and 1 mg. It includes storage instructions and manufacturer details, mentioning Florida Pharmaceutical Products, LLC as the labeler. The panel also notes dispensing the Medication Guide to patients.*

FDA Label Image

Label-starting-pack-blister (Label Starting Pack Blister)

Label for Varenicline Tablets Starting Pack from Florida Pharmaceutical Products, LLC. Includes blister card layout for starting week (0.5 mg strength) and continuing weeks (1 mg strength), with detailed blister card days and dosing instructions. Label states storage instructions, dosage information, manufacturer details, and includes a barcode. Direction to dispense accompanying medication guide is noted.*

FDA Label Image

Structure (Structure)

Chemical structure of varenicline tartrate, depicting the molecular arrangement of varenicline on the left and the tartrate moiety on the right.*

FDA Label Image

Vareni-container-label-mg (Vareni Container Label mg)

Label for Varenicline Tablets 0.5 mg film-coated oral tablets manufactured by Indoco Remedies Limited and labeled by Florida Pharmaceutical Products, LLC. The label includes storage instructions, dosage form, quantity of 56 tablets, and a barcode. It specifies that each tablet contains 0.85 mg of varenicline tartrate equivalent to 0.5 mg varenicline base and warns to dispense the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.